KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Inovio Pharmaceuticals (INO) Other Operating Expenses (2016 - 2023)

Historic Other Operating Expenses for Inovio Pharmaceuticals (INO) over the last 9 years, with Q3 2023 value amounting to $10.5 million.

  • Inovio Pharmaceuticals' Other Operating Expenses changed N/A to $10.5 million in Q3 2023 from the same period last year, while for Jun 2024 it was $10.5 million, marking a year-over-year change of. This contributed to the annual value of $10.5 million for FY2023, which is N/A changed from last year.
  • Inovio Pharmaceuticals' Other Operating Expenses amounted to $10.5 million in Q3 2023.
  • In the past 5 years, Inovio Pharmaceuticals' Other Operating Expenses ranged from a high of $10.5 million in Q3 2023 and a low of $10.5 million during Q3 2023